Vincristine shortage underscores vulnerability of ‘fragile market’ for crucial treatments

October 23, 2019
A shortage of the chemotherapy drug vincristine, which is essential to the treatment of most pediatric cancers, has left the oncology community…

Deadliest cancers receive less research funding from patient advocacy groups

October 23, 2019
Cancer-related nonprofit organizations play a crucial role in supporting medical research and patient advocacy, generating nearly $6 billion in…

NCI-sponsored clinical trials cost-effective, ‘practice influential’

October 22, 2019
A study by the NCI-sponsored SWOG Cancer Research Network showed nearly half of the network’s phase 3 clinical trials influenced clinical care…

ID1 inhibition may improve efficacy of glioblastoma treatment

October 18, 2019
Investigators from St. Michael’s Hospital and The Hospital for Sick Children in Toronto have determined that the transcriptional regulatory…

Analysis confirms RFS benefit of adjuvant high-dose interferon alpha in melanoma

October 15, 2019
Adjuvant high-dose interferon alpha continued to demonstrate improvements in RFS and melanoma-specific survival among patients with resected…

Biocompatible ‘lab on a chip’ shows potential in development of antiplatelet therapies

October 10, 2019
A novel biocompatible “lab-on-a-chip” device may help accelerate the discovery and development of new antiplatelet therapies, according…
Molecular Oncology

Precision oncology: Exciting clinical developments and complicated biology

HemOnc Today, October 10, 2019
Wafik S. El-Deiry, MD, PhD, FACP
Exciting developments in molecular oncology within the past few months include impressive clinical results of a novel drug that targets RET fusions…

Hope vs Hype: Managing Patient Expectations for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Imagine a young adult male in his late 20s picks up his cell phone and calls his mother. Overtly emotional and on the verge of releasing a full-out…
Cover Story

Developing a Pause Button for CAR T-Cell Therapy

Cell Therapy Next, October/November 2019
Chimeric antigen receptor T-cell therapy has proven to be a life-changing development for those with advanced, treatment refractory leukemia and…

Formulation could reduce toxicities of head and neck cancer chemoradiotherapy

October 7, 2019
Researchers at Purdue University and Indiana University School of Medicine have developed a novel chemoradiotherapy formulation that could decrease…